An antiviral drug called remdesivir is the first treatment to show efficacy against the coronavirus. Preliminary results from a clinical trial comparing the drug with a placebo suggest that ...
The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy. The EMA’s human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback